Evidence map›Paper›PMID 29956576›Full record

ReviewInternational review of psychiatry (Abingdon, England)2018

Impact of cannabis legalization on treatment and research priorities for cannabis use disorder.

Gregory L Sahlem, Rachel L Tomko, Brian J Sherman, Kevin M Gray, Aimee L McRae-Clark

Abstract readReview
In one paragraph

Review in International review of psychiatry (Abingdon, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. 3-Year Follow-up of Lower Risk Cannabis Use Patterns: Evidence from a Longitudinal Survey.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2022
    Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gregory L Sahlema Department of Psychiatry , Medical University of South Carolina , Charleston , SC , USA.
Rachel L Tomkoa Department of Psychiatry , Medical University of South Carolina , Charleston , SC , USA.
Brian J Shermana Department of Psychiatry , Medical University of South Carolina , Charleston , SC , USA.
Kevin M Graya Department of Psychiatry , Medical University of South Carolina , Charleston , SC , USA.
Aimee L McRae-Clarka Department of Psychiatry , Medical University of South Carolina , Charleston , SC , USA.

Funding

Clinical Scientists Training Program in Addictions at MUSCK12DA031794 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Kevin M. Gray, AIMEE L MCRAE-CLARK · 2013 to 2026
$7.2M
A Randomized Controlled Trial of Varenicline for Adolescent Smoking CessationU01DA031779 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRAY, KEVIN M · 2012 to 2016
$3.3M
N-Acetylcysteine and Contingency Management for Youth Cannabis Use DisorderR01DA042114 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRAY, KEVIN M · 2017 to 2021
$3.1M
MID-CAREER AWARD IN PATIENT-ORIENTED DRUG ABUSE RESEARCHK24DA038240 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCRAE-CLARK, AIMEE L · 2014 to 2023
$1.9M
Advancing Varenicline as a Treatment for Cannabis Use DisorderUG3DA043231 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRAY, KEVIN M, MCRAE-CLARK, AIMEE L · 2016 to 2017
$1.7M
A Preliminary Investigation of Pre-Frontal repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use DisorderK23DA043628 · NIDA · STANFORD UNIVERSITY · PI SAHLEM, GREGORY · 2017 to 2022
$933k
NIDA NIH HHS K12 DA031794NIDA NIH HHS K23 DA043628NIDA NIH HHS K24 DA038240NIDA NIH HHS R01 DA042114NIDA NIH HHS U01 DA031779NIDA NIH HHS UG3 DA043231
6 · The paper itself

Abstract

An increasing proportion of the world has legalized cannabis for medicinal or recreational use. The legalization trend appears to be continuing. These changes in the legislative landscape may have important health, treatment, and research implications. This review discusses public health outcomes that may be impacted by increases in cannabis availability and use. It additionally considers potential research and treatment priorities in the face of widespread cannabis legalization.

Indexed as

CannabisLegislation, DrugMarijuana UsePublic HealthHumansCannabiscannabis use disorderlegalizationmarijuanatreatment

Identifiers

PMID29956576
PMCPMC6322658

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.